Automated data processing of {1H-decoupled} 13C MR spectra acquired from human brain in vivo

Journal of Magnetic Resonance

Volumn 162, Issue 2, 2003, Pages 259-268

  Shic, Frederick ^a   Ross, Brian ^b  

^a Rudi Schulte Research Institute   (United States)

^b HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

Author keywords

13C; Alzheimer; Epilepsy; Glia; Glutamate; In vivo human brain; Ketogenic diet; Neuron; Spectroscopy processing

Indexed keywords

BRAIN; DISEASES; MAGNETIC RESONANCE IMAGING; METABOLITES; OPTICAL DATA PROCESSING; PATHOLOGY; SPECTROSCOPIC ANALYSIS;

NEURONS;

HUMAN ENGINEERING;

EID: 0041492749     PISSN: 10907807     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1090-7807(03)00117-4     Document Type: Article

References (25)

1. Beckmann N., Fried R., Turkalj I., Seelig J., Keller U., Stalder G. Non-invasive observation of hepatic glycogen formation in man by 13C MRS after oral and intravenous glucose administration. Magn. Reson. Med. 29:1993;583.
2. Mason G.F., Gruetter R., Rothman D.L., Behar K.L., Shulman R.G., Novotny E.J. Simultaneous determination of the rates of the TCA cycle, glucose utilization, α-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR. J. Cereb. Blood Flow Metab. 15:1995;12.
3. Choi I., Tkac I., Ugurbil K., Gruetter R. Noninvasive measurement of [1-13C]glycogen concentrations and metabolism in rat brain in vivo. J. Neurochem. 73:1999;1300.
4. Bluml S., Moreno A., Hwang J.-H., Ross B.D. [1-13C]glucose magnetic resonance spectroscopy of pediatric and adult brain disorders. NMR Biomed. 14:2001;19.
5. Rothman D.L., Sibson N.R., Hyder F., Shen J., Behar K.L., Shulman R.G. In vivo nuclear magnetic resonsance spectroscopy studies of the relationship between the glutamate and glutamine neurotransmitter cycle and functional neuroenergetics. Philos. Trans. Roy. Soc. Lond. 354:1999;1165.
6. Bluml S., Moreno-Torres A., Shic F., Nguy C.-H., Ross B.D. Tricarboxylic acid cycle of glia in the in vivo human brain. NMR Biomed. 15:2002;1.
7. Gruetter R., Seaquist E.R., Ugurbil K. A mathematical model of compartmentalized neurotransmitter metabolism in the human brain. Am. J. Physiol. Endocrinol. Metab. 281:2001;E100.
8. Magistretti P.J., Pellerin L., Rothman D.L., Shulman R.G. Energy on demand. Science. 283:1999;496.
9. Choi D.W. Glutamate neurotoxicity and disease of the nervous system. Neuron. 1:1988;623.
10. Bluml S., Moreno-Torres A., Ross B.D. [1-13C]Glucose MRS in chronic hepatic encephalopathy in man. Magn. Reson. Med. 45:2001;981.
11. Shic F., Ross B.D., Yahya K., Lin A., Lai L., Bluml S. A protocol for the synchronous assay of in vivo glial and neuronal metabolic rates in man. Proc. Int. Soc. Mag. Reson. Med. 1:2002;234. 10 Honolulu, Hawaii, USA.
12. Lebon V., Kitt P.F., Cline G.W., Shen J., Mason G.F., Dufour S., Behar K.L., Shulman G.I., Rothman D.L. Astroglial contribution to brain energy metabolism in humans revealed by 13C nuclear magnetic resonance spectroscopy: Elucidation of the dominant pathway for neurotransmitter glutamate repletion and measurement of astrocytic oxidative metabolism. J. Neurosci. 22:2002;1523.
13. London R.E. 13C Labelling in studies of metabolic regulation. Prog. NMR Spectrosc. 20:1988;337.
14. Moreno A., Bluml S., Hwang J.-H., Ross B.D. Alternative [1-13C]glucose infusion protocols for clinical 13C MRS examinations of the brain. Magn. Reson. Med. 46:2001;36.
15. Bluml S. In vivo quantitation of cerebral metabolites concentration using natural abundance 13C MRS at 1.5 T. J. Magn. Reson. 136:1999;219.
16. Bluml S., Hwang J.-H., Moreno A., Ross B.D. Novel peak assignments of in vivo 13C MRS in human brain at 1.5 T. J. Magn. Reson. 143:2000;292.
17. Press W.H., Flannery B.P., Teukolsky S.A., Vetterling W.T. Numerical Recipes in C: The Art of Scientific Computing. 1993;Cambridge University Press, Cambridge.
18. Ernst T., Kreis R., Ross B.D. Absolute quantitation of water and metabolites in the human brain. I. Compartments and water. J. Magn. Reson. 102:1993;1.
19. Kreis R., Ernst T., Ross B.D. Absolute quantitation of water and metabolites in the human brain. Part II: Metabolite concentrations. J. Magn. Reson. 102:1993;9.
20. S.A. Rauch, Advanced System Design and Development: XlXtrFun.xll(c). 〈http://www.netrax.net/̃jdavita/XlXtrFun.htm〉 (1993-1999).
21. Lin A.P., Shic F., Enriquez C., Ross B.D. Evidence of reduced glutamate neurotransmission in patients with Alzheimer's disease - An in vivo 13C MRS study. MAGMA. 2003;29.
22. Henry P.G., Tkac I., Gruetter R. Automatic quantitation of in vivo 13C spectra using LCModel. Proc. Int. Soc. Mag. Reson. Med. 1:2002;530. 10 Honolulo, Hawaii, USA.
23. Moreno A., Ross B.D., Bluml S. Direct determination of the N-acetyl-L-aspartate synthesis rate in the human brain by 13C MRS and [1-13C]glucose infusion. J. Neurochem. 77:2001;347.
24. Bluml S., Shic F., Lai L., Yahya K., Lin A., Ross B.D. Glutamate-glutamine cycling in epileptic patients on ketogenic diets. Proc. Int. Soc. Mag. Reson. Med. 1:2002;417. 10, Honolulu, Hawaii, USA.
25. F. Shic, L. Lai, A. Lin, K. Yahya, A. Moreno, S. Bluml, B.D. Ross, 13C Glucose magnetic resonance spectroscopy of neurodegenerative disorders, in: 8th International Conference of Alzheimer's Disease and Related Disorders, Stockholm, Sweden, vol., 2002.